Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 379

1.
2.

Prediction of hemorrhagic transformation after thrombolytic therapy of clot embolism: an MRI investigation in rat brain.

Neumann-Haefelin C, Brinker G, Uhlenküken U, Pillekamp F, Hossmann KA, Hoehn M.

Stroke. 2002 May;33(5):1392-8.

PMID:
11988620
[PubMed - indexed for MEDLINE]
Free Article
3.

Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function.

Gautier S, Petrault O, Gele P, Laprais M, Bastide M, Bauters A, Deplanque D, Jude B, Caron J, Bordet R.

Stroke. 2003 Dec;34(12):2975-9. Epub 2003 Nov 13.

PMID:
14615621
[PubMed - indexed for MEDLINE]
Free Article
4.

Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.

Niessen F, Hilger T, Hoehn M, Hossmann KA.

Stroke. 2003 Aug;34(8):2019-24. Epub 2003 Jul 3.

PMID:
12843350
[PubMed - indexed for MEDLINE]
Free Article
5.

Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging.

Dijkhuizen RM, Asahi M, Wu O, Rosen BR, Lo EH.

J Cereb Blood Flow Metab. 2001 Aug;21(8):964-71.

PMID:
11487732
[PubMed - indexed for MEDLINE]
Free Article
6.

Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.

Pfefferkorn T, Rosenberg GA.

Stroke. 2003 Aug;34(8):2025-30. Epub 2003 Jul 10.

PMID:
12855824
[PubMed - indexed for MEDLINE]
Free Article
7.

Magnetic resonance imaging characterization of hemorrhagic transformation of embolic stroke in the rat.

Jiang Q, Zhang RL, Zhang ZG, Knight RA, Ewing JR, Ding G, Lu M, Arniego P, Zhang L, Hu J, Li Q, Chopp M.

J Cereb Blood Flow Metab. 2002 May;22(5):559-68.

PMID:
11973428
[PubMed - indexed for MEDLINE]
Free Article
8.

Thrombolytic treatment of clot embolism in rat: comparison of intra-arterial and intravenous application of recombinant tissue plasminogen activator.

Niessen F, Hilger T, Hoehn M, Hossmann KA.

Stroke. 2002 Dec;33(12):2999-3005.

PMID:
12468803
[PubMed - indexed for MEDLINE]
Free Article
9.

Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia.

Qin Z, Karabiyikoglu M, Hua Y, Silbergleit R, He Y, Keep RF, Xi G.

Stroke. 2007 Apr;38(4):1362-7. Epub 2007 Feb 22.

PMID:
17322079
[PubMed - indexed for MEDLINE]
Free Article
10.

Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.

Morris DC, Zhang L, Zhang ZG, Lu M, Berens KL, Brown PM, Chopp M.

Stroke. 2001 Nov;32(11):2635-40.

PMID:
11692028
[PubMed - indexed for MEDLINE]
Free Article
11.

Hemorrhagic transformation after fibrinolysis with tissue plasminogen activator: evaluation of role of hypertension with rat thromboembolic stroke model.

Tejima E, Katayama Y, Suzuki Y, Kano T, Lo EH.

Stroke. 2001 Jun;32(6):1336-40.

PMID:
11387496
[PubMed - indexed for MEDLINE]
Free Article
12.

Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats.

Knight RA, Barker PB, Fagan SC, Li Y, Jacobs MA, Welch KM.

Stroke. 1998 Jan;29(1):144-51.

PMID:
9445344
[PubMed - indexed for MEDLINE]
Free Article
13.

Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.

Zhang L, Zhang ZG, Zhang RL, Lu M, Krams M, Chopp M.

Stroke. 2003 Jul;34(7):1790-5. Epub 2003 Jun 12.

PMID:
12805500
[PubMed - indexed for MEDLINE]
Free Article
14.

Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.

Maeda M, Furuichi Y, Noto T, Matsuoka N, Mutoh S, Yoneda Y.

Brain Res. 2009 Feb 13;1254:99-108. doi: 10.1016/j.brainres.2008.11.080. Epub 2008 Dec 3.

PMID:
19101526
[PubMed - indexed for MEDLINE]
15.

Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.

Thomalla G, Sobesky J, Köhrmann M, Fiebach JB, Fiehler J, Zaro Weber O, Kruetzelmann A, Kucinski T, Rosenkranz M, Röther J, Schellinger PD.

Stroke. 2007 Feb;38(2):313-8. Epub 2007 Jan 4.

PMID:
17204683
[PubMed - indexed for MEDLINE]
Free Article
16.

Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.

Zhang Z, Zhang L, Yepes M, Jiang Q, Li Q, Arniego P, Coleman TA, Lawrence DA, Chopp M.

Circulation. 2002 Aug 6;106(6):740-5.

PMID:
12163437
[PubMed - indexed for MEDLINE]
Free Article
17.

Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.

Copin JC, Gasche Y.

Brain Res. 2008 Dec 3;1243:161-6. doi: 10.1016/j.brainres.2008.09.025. Epub 2008 Sep 19.

PMID:
18835259
[PubMed - indexed for MEDLINE]
18.

Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.

Zhang L, Zhang ZG, Ding GL, Jiang Q, Liu X, Meng H, Hozeska A, Zhang C, Li L, Morris D, Zhang RL, Lu M, Chopp M.

Circulation. 2005 Nov 29;112(22):3486-94.

PMID:
16316970
[PubMed - indexed for MEDLINE]
Free Article
19.
20.

Analysis of combined treatment of embolic stroke in rat with r-tPA and a GPIIb/IIIa inhibitor.

Ding G, Jiang Q, Zhang L, Zhang ZG, Li L, Knight RA, Ewing JR, Wang Y, Chopp M.

J Cereb Blood Flow Metab. 2005 Jan;25(1):87-97.

PMID:
15678115
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk